Similar articles for PMID: 19029516

Year	Number of Results
1993	1
1994	1
1995	2
1996	6
1997	1
1998	2
2001	1
2002	2
2003	3
2004	3
2005	5
2006	2
2007	5
2008	1
2009	7
2010	7
2011	3
2012	5
2013	2
2014	4
2015	6
2016	3
2017	7
2018	9
2019	7
2020	4
2021	2
2022	4
2023	4
2024	0

1

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.

Sorenson EJ, Windbank AJ, Mandrekar JN, Bamlet WR, Appel SH, Armon C, Barkhaus PE, Bosch P, Boylan K, David WS, Feldman E, Glass J, Gutmann L, Katz J, King W, Luciano CA, McCluskey LF, Nash S, Newman DS, Pascuzzi RM, Pioro E, Sams LJ, Scelsa S, Simpson EP, Subramony SH, Tiryaki E, Thornton CA. Sorenson EJ, et al. Neurology. 2008 Nov 25;71(22):1770-5. doi: 10.1212/01.wnl.0000335970.78664.36. Neurology. 2008. PMID: 19029516 Free PMC article. Clinical Trial.

2

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group.

Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, Silani V, Vos PE, Wokke JH, Dobbins T. Borasio GD, et al. Neurology. 1998 Aug;51(2):583-6. doi: 10.1212/wnl.51.2.583. Neurology. 1998. PMID: 9710040 Clinical Trial.

3

Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.

Mitchell JD, Wokke JH, Borasio GD. Mitchell JD, et al. Cochrane Database Syst Rev. 2002;(3):CD002064. doi: 10.1002/14651858.CD002064. Cochrane Database Syst Rev. 2002. PMID: 12137643 Updated. Review.

4

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH. Miller RG, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 13129806 Review.

5

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.

Beauverd M, Mitchell JD, Wokke JH, Borasio GD. Beauverd M, et al. Cochrane Database Syst Rev. 2012 Nov 14;11:CD002064. doi: 10.1002/14651858.CD002064.pub3. Cochrane Database Syst Rev. 2012. PMID: 23152212 Review.

6

A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.

Lenglet T, Lacomblez L, Abitbol JL, Ludolph A, Mora JS, Robberecht W, Shaw PJ, Pruss RM, Cuvier V, Meininger V; Mitotarget study group. Lenglet T, et al. Eur J Neurol. 2014 Mar;21(3):529-36. doi: 10.1111/ene.12344. Epub 2014 Jan 21. Eur J Neurol. 2014. PMID: 24447620 Clinical Trial.

7

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group.

[No authors listed] [No authors listed] Neurology. 1996 May;46(5):1244-9. doi: 10.1212/wnl.46.5.1244. Neurology. 1996. PMID: 8628460 Clinical Trial.

8

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.

Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Murphy MF, Natter HM, Norris FH, Rudnicki SA. Lai EC, et al. Neurology. 1997 Dec;49(6):1621-30. doi: 10.1212/wnl.49.6.1621. Neurology. 1997. PMID: 9409357 Clinical Trial.

9

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J; Northeast ALS Consortium. Cudkowicz ME, et al. Neurology. 2003 Aug 26;61(4):456-64. doi: 10.1212/wnl.61.4.456. Neurology. 2003. PMID: 12939417 Clinical Trial.

10

A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.

Saccà F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G, Carotenuto B, Marsili A, Palma V, De Michele G, Brunetti A, Brescia Morra V, Filla A, Salvatore M. Saccà F, et al. J Neurol. 2012 Jan;259(1):132-8. doi: 10.1007/s00415-011-6146-2. Epub 2011 Jun 25. J Neurol. 2012. PMID: 21706151 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year